Life and death in the thymus—cell death signaling during T cell development
Introduction
Among the first cell types to be characterized as undergoing steady state cell death, thymocytes offer valuable insight into the regulation of organ system development and tissue homeostasis. The thymus itself directs the process of early T cell differentiation, and a number of developmental stages depend on life vs. death choices that are intricately programmed. Perhaps unique to the genesis of lymphocytes, the essentially stochastic process involved in the rearrangement of T and B cell antigen receptor genes requires subsequent selective mechanisms that ensure that antigen receptors are minimally functional without being autoreactive. Indeed, the deletion of autoreactive lymphocytes is one of the key means by which ‘immunological tolerance,’ the prevention of autoreactivity, is achieved. This elimination of autoreactive lymphocytes during their development is termed ‘central tolerance,’ and is the primary means of elimination of lymphocytes that would otherwise potentiate autoimmune disease. Programmed mechanisms that modulate cell survival vs. cell death are essential for many of these selective processes. Once functional lymphocytes are produced and released to the periphery, additional cell death mechanisms control lymphoid homeostasis, and provide a secondary layer of self-tolerance termed ‘peripheral tolerance.’ Our focus in this review is specifically directed toward the cell death processes that occur within the thymus. For those interested in peripheral tolerance and lymphoid homeostasis, the reader is directed to other reviews on the subject.
Section snippets
Survival and death of early thymocytes, the ‘double-negative’ sub-populations
A thymocyte is first generated from the interaction of a hematopoietic stem cell with a thymic stromal cell. In order for a thymocyte to differentiate into a mature T lymphocyte it must go through maturational stages. The first stage is termed the double negative (DN) stage because thymocytes in this stage lack the CD4 or CD8 co-receptors. The double negative stage can be broken down even further into four successive developmental subsets based on the cell surface expression of the CD117, CD44,
Death at the CD4/CD8 double positive developmental stage of thymopoiesis
During the DN4 precursor stage of thymocyte development, TCR α chain rearrangement ensues, resulting in the display of a fully assembled TCR. As thymocytes transit to the double positive (DP) stage, these thymocytes enter a period of quiescence that lasts an average of three to four days. Several survival factors are expressed that allow the opportunity to test the newly displayed TCR. This ‘TCR selection’ is imperative, as it will lead to three potential fates as dictated by the strength of
Conclusions
The thymus is an essential organ system that is imbued with the significant task of orchestrating the development of functional T cells, and the prevention of systemic autoimmunity. As described in this review, the proper regulation of cell death is vital to the function of the thymus. Although the function of the thymus wanes as humans reach adulthood, it remains active throughout one's lifetime. The intricate control over myriad cell survival and death processes in the thymus underscores the
References and recommended reading
Papers of particular interest, published within the period of review, have been highlighted as:
• of special interest
•• of outstanding interest
Acknowledgements:
This work was supported by grants from the NIH (CMW: R01 AI63419, AI50506; RHN: immunology training grant T32-AI60573), the National Multiple Sclerosis Foundation, the Arthritis National Research Foundation, and the Juvenile Diabetes Research Foundation.
References (57)
- et al.
Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo
Immunity
(1995) - et al.
Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice
Immunity
(1997) - et al.
Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival
J Biol Chem
(2004) - et al.
FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells
Proc Natl Acad Sci USA
(2008) Signal strength in thymic selection and lineage commitment
Curr Opin Immunol
(2001)- et al.
c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation
J Exp Med
(2001) - et al.
Disruption of T cell signaling networks and development by Grb2 haploid insufficiency
Nat Immunol
(2001) - et al.
Signaling by the kinase MINK is essential in the negative selection of autoreactive thymocytes
Nat Immunol
(2005) - et al.
Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene
Proc Natl Acad Sci USA
(1994) - et al.
Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes
Proc Natl Acad Sci USA
(2001)
No requirement for TRAIL in intrathymic negative selection
Int Immunol
Caspases in cell survival, proliferation and differentiation
Cell Death Differ
A developmental pathway involving four phenotypically and functionally distinct subsets of CD3−CD4−CD8− triple-negative adult mouse thymocytes defined by CD44 and CD25 expression
J Immunol
A survival guide to early T cell development
Immunol Res
Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine
J Exp Med
Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice
J Exp Med
Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice
J Exp Med
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Nature
Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH
Proc Natl Acad Sci USA
Mcl-1 promotes survival of thymocytes by inhibition of Bak in a pathway separate from Bcl-2
Cell Death Differ
Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells
Nature
The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival
J Exp Med
Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation
Proc Natl Acad Sci USA
CXCR4 acts as a costimulator during thymic beta-selection
Nat Immunol
A role for FADD in T cell activation and development
Immunity
FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor
EMBO J
Positive and negative selection of T cells
Annu Rev Immunol
Requirement for RORgamma in thymocyte survival and lymphoid organ development
Science
Cited by (52)
Attenuation of apoptotic cell detection triggers thymic regeneration after damage
2021, Cell ReportsCitation Excerpt :We found that the intracellular pattern recognition receptor NOD2, via induction of microRNA-29c, suppressed levels of the regenerative factors IL-23 and BMP4, in DCs and ECs, respectively. During steady-state T cell development, a high proportion of thymocytes undergo apoptosis due to selection events during T cell development (Hernandez et al., 2010; Jameson et al., 1995). We demonstrate that this provides a signal for a suppressive pathway that is constitutively activated by the detection of exposed phosphatidylserine on apoptotic cells by cell-surface TAM receptors (Rothlin et al., 2015) on DCs and ECs, with downstream intracellular activation of the Rho GTPase Rac1.
Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation
2019, Journal of Molecular and Cellular CardiologyCitation Excerpt :To confirm that DR5 activation produces hypertrophy in vivo, C57BL/6 mice were administered the DR5 agonist antibody, MD5–1, or IgG control for two weeks according to the treatment regime outlined in the methods. Decreased thymus weight (Supplementary Fig. 4A) and increased thymocyte apoptosis (Supplementary Fig. 4B) was assessed to confirm MD5–1 administration activated DR5 in vivo since DR5 agonist administration is known to cause thymocyte apoptosis [27]. Immunoblot analysis of ERK1/2 activation in hearts from mice injected with MD5–1 or IgG control showed an increase in phospho-ERK1/2 levels with MD5–1 treatment (Fig. 4A).
Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology
2019, ImmunityCitation Excerpt :This is based on several observations. First, apoptosis can be selectively induced in normal cells due to lack of growth factors or survival signals (e.g., lymphoid progenitors, activated B and T cells, neuronal progenitor cells, spontaneous neutrophil apoptosis) (Hildeman et al., 2007; Kristiansen and Ham, 2014), lack of a proper selection or survival signal (e.g., thymic selection of T cells) (Hernandez et al., 2010; Surh and Sprent, 1994), or actively (such as Fas-induced apoptosis) (Nagata, 1999). Second, when multiple pro-apoptotic genes are mutated and thereby apoptosis is dampened, less than 1% of these animals survive (Ke et al., 2018).
- 1
These authors contributed equally.